These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31560147)

  • 1. Vitamin K
    Xu W; Meng K; Wu H; Miura T; Suzuki S; Chiyotanda M; Tanaka S; Sugiyama K; Kawashima H; Hirano T
    Pediatr Int; 2019 Dec; 61(12):1188-1195. PubMed ID: 31560147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K2 Suppresses Proliferation and Inflammatory Cytokine Production in Mitogen-Activated Lymphocytes of Atopic Dermatitis Patients through the Inhibition of Mitogen-Activated Protein Kinases.
    Zhang M; Miura T; Suzuki S; Chiyotanda M; Tanaka S; Sugiyama K; Kawashima H; Hirano T
    Biol Pharm Bull; 2021; 44(1):7-17. PubMed ID: 33390552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of vitamin K1 and vitamin K2 on the proliferation, cytokine production and regulatory T-cell frequency in peripheral blood mononuclear cells of paediatric atopic dermatitis patients.
    Meng K; Xu W; Miura T; Suzuki S; Chiyotanda M; Tanaka S; Sugiyama K; Kawashima H; Hirano T
    Exp Dermatol; 2018 Sep; 27(9):1058-1060. PubMed ID: 29697859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vitamin K
    Xu W; Wu H; Tahara K; Chen S; Wang X; Tanaka S; Sugiyama K; Sawada T; Hirano T
    Fundam Clin Pharmacol; 2021 Oct; 35(5):832-842. PubMed ID: 33780033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K1 and Vitamin K2 immunopharmacological effects on the peripheral lymphocytes of healthy subjects and dialysis patients, as estimated by the lymphocyte immunosuppressant sensitivity test.
    Kusano J; Tanaka S; Matsuda H; Hara Y; Fujii Y; Suzuki S; Sekiyama M; Ando E; Sugiyama K; Hirano T
    J Clin Pharm Ther; 2018 Dec; 43(6):895-902. PubMed ID: 30014604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive effect of vitamin K2 against mitogen-activated peripheral blood mononuclear cells of rheumatoid arthritis patients.
    Xu W; Chen S; Wang X; Tahara K; Wu H; Tanaka S; Sugiyama K; Sawada T; Hirano T
    Int J Clin Pharmacol Ther; 2021 Jan; 59(1):55-62. PubMed ID: 33040843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis.
    Furukawa H; Nakamura K; Zheng X; Tojo M; Oyama N; Akiba H; Nishibu A; Kaneko F; Tsunemi Y; Saeki H; Tamaki K
    J Dermatol Sci; 2004 Jun; 35(1):35-42. PubMed ID: 15194145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive efficacy of tetrandrine combined with methylprednisolone against mitogen-activated peripheral blood mononuclear cells of haemodialysis patients.
    Xu W; Meng K; Kusano J; Matsuda H; Hara Y; Fujii Y; Suzuki S; Ando E; Wang X; Tu Y; Tanaka S; Sugiyama K; Yamada H; Hirano T
    Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):924-931. PubMed ID: 28613399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with antineutrophil cytoplasmic antibody-associated vasculitis and nephrosis.
    Hirano T; Fukushima H; Sasaki Y; Yoshikawa N; Yoshida M; Oka K
    Int Immunopharmacol; 2006 Jun; 6(6):924-34. PubMed ID: 16644478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of peripheral blood lymphocyte sensitivity to glucocorticoids for the differentiation of high-risk patients with decreased allograft function after glucocorticoid withdrawal in renal transplantation.
    Muhetaer G; Takeuchi H; Unezaki S; Kawachi S; Iwamoto H; Nakamura Y; Shimazu M; Sugiyama K; Hirano T
    Clin Ther; 2014 Aug; 36(8):1264-72. PubMed ID: 25037282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased sensitivities of peripheral blood mononuclear cells to immunosuppressive drugs in cirrhosis patients awaiting liver transplantation.
    Mijiti A; Matsuno N; Iwahori T; Takeuchi H; Nagao T; Oka K; Hirano T
    Cell Transplant; 2006; 15(10):885-91. PubMed ID: 17299993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive potencies of calcineurin inhibitors against the mitogen-induced blastogenesis of peripheral-blood mononuclear cells of myasthenia gravis patients.
    Tanaka S; Nakajima K; Hirano T; Oka K; Saito T; Wakata N
    J Pharm Pharmacol; 2008 Oct; 60(10):1341-6. PubMed ID: 18812027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of immune response to Staphylococcus aureus superantigens and disease severity in relation to the sensitivity to tacrolimus in atopic dermatitis.
    Fukushima H; Hirano T; Shibayama N; Miwa K; Ito T; Saito M; Sumida H; Oyake S; Tsuboi R; Oka K
    Int Arch Allergy Immunol; 2006; 141(3):281-9. PubMed ID: 16931890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with chronic renal failure on hemodialysis treatment.
    Konno O; Hirano T; Katsuyama K; Oka K; Matsuno N; Nagao T
    Transpl Immunol; 2007 Apr; 17(3):187-92. PubMed ID: 17331845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen.
    Arai K; Uchiyama T; Okubo Y; Tsuboi R; Oka K; Hirano T
    Eur J Pharmacol; 2007 Oct; 571(2-3):222-30. PubMed ID: 17628528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids).
    Sakuma S; Higashi Y; Sato N; Sasakawa T; Sengoku T; Ohkubo Y; Amaya T; Goto T
    Int Immunopharmacol; 2001 Jun; 1(6):1219-26. PubMed ID: 11407316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of topically applied tacrolimus ointment in patients with moderate to severe atopic dermatitis.
    Wong WR; Tsai HJ; Hong HS
    Chang Gung Med J; 2003 Jul; 26(7):485-95. PubMed ID: 14515971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of insulin on pharmacodynamics of immunosuppressive drugs against mitogen-activated human peripheral blood mononuclear cells.
    Chen S; Sugiyama K; Inamura M; Tanaka S; Onda K; Yin H; Hirano T
    Immunopharmacol Immunotoxicol; 2016 Oct; 38(5):372-8. PubMed ID: 27443993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus abrogates TGF-β1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway: implications on treatment of chronic atopic dermatitis lesions.
    Lan CC; Fang AH; Wu PH; Wu CS
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):204-15. PubMed ID: 23301526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.